Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Strang

Showing results (261-270 of 303) with videos related to

Pageof 31
Sort By:
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Addiction (Abingdon, England)|July 14, 2011
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individualsLeslie Amass, Vilma Pukeleviciene, Emilis Subata, et al.
Neuroimage. Clinical|October 21, 2015
Default mode network segregation and social deficits in autism spectrum disorder: Evidence from non-medicated childrenBenjamin E Yerys, Evan M Gordon, Danielle N Abrams, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2022
Correction to: Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†John Strang, Teodora Groshkova, Ambros Uchtenhagen, et al.
Lancet (London, England)|April 15, 2014
Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trialTim Weaver, Nicola Metrebian, Jennifer Hellier, et al.
Addiction (Abingdon, England)|October 11, 2023
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over studyDominic Oliver, Amir Englund, Edward Chesney, et al.
BMJ Open Quality|February 15, 2022
Golden opportunity for intervention? Identifying vitamin D deficiency in patients with substance use disorders in hospitalE Naomi Smith, Siobhan Gee, Gerri O'Brien, et al.
Addiction (Abingdon, England)|April 24, 2019
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorderMichael Frost, Genie L Bailey, Nicholas Lintzeris, et al.
Trials|October 25, 2016
A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trialSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
Pageof 31

Showing results (261-270 of 303) with videos related to

Sort By:
Pageof 31
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 16, 2022
Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
Addiction (Abingdon, England)|July 14, 2011
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individualsLeslie Amass, Vilma Pukeleviciene, Emilis Subata, et al.
Neuroimage. Clinical|October 21, 2015
Default mode network segregation and social deficits in autism spectrum disorder: Evidence from non-medicated childrenBenjamin E Yerys, Evan M Gordon, Danielle N Abrams, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 24, 2022
Correction to: Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?Ranjita Dhital, Rachel Coleman, Ed Day, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2015
Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†John Strang, Teodora Groshkova, Ambros Uchtenhagen, et al.
Lancet (London, England)|April 15, 2014
Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trialTim Weaver, Nicola Metrebian, Jennifer Hellier, et al.
Addiction (Abingdon, England)|October 11, 2023
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over studyDominic Oliver, Amir Englund, Edward Chesney, et al.
BMJ Open Quality|February 15, 2022
Golden opportunity for intervention? Identifying vitamin D deficiency in patients with substance use disorders in hospitalE Naomi Smith, Siobhan Gee, Gerri O'Brien, et al.
Addiction (Abingdon, England)|April 24, 2019
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorderMichael Frost, Genie L Bailey, Nicholas Lintzeris, et al.
Trials|October 25, 2016
A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trialSonia Johnson, Luke Sheridan Rains, Steven Marwaha, et al.
Pageof 31